TY - JOUR
T1 - Bisphosphonates and Oral Health
T2 - Primer and an Update for the Practicing Surgeon
AU - Assael, Leon A.
PY - 2011/8
Y1 - 2011/8
N2 - Oral and intravenous bisphosphonates have been in clinical use for two decades for the treatment of patients with malignancy, osteoporosis, and other diseases affecting bone metabolism. The purpose of this article is to review the features of these drugs, their effect on the diseases they treat, the oral findings associated with their use, and the assessment of osteonecrosis incidence, pathophysiology, with some insights into treatment.
AB - Oral and intravenous bisphosphonates have been in clinical use for two decades for the treatment of patients with malignancy, osteoporosis, and other diseases affecting bone metabolism. The purpose of this article is to review the features of these drugs, their effect on the diseases they treat, the oral findings associated with their use, and the assessment of osteonecrosis incidence, pathophysiology, with some insights into treatment.
KW - Bisphosphonates
KW - Bone metabolism
KW - Oral health osteoporosis
UR - http://www.scopus.com/inward/record.url?scp=79960675134&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960675134&partnerID=8YFLogxK
U2 - 10.1016/j.coms.2011.04.002
DO - 10.1016/j.coms.2011.04.002
M3 - Review article
C2 - 21798442
AN - SCOPUS:79960675134
SN - 1042-3699
VL - 23
SP - 443
EP - 453
JO - Oral and Maxillofacial Surgery Clinics of North America
JF - Oral and Maxillofacial Surgery Clinics of North America
IS - 3
ER -